Glycopeptides of hMOG(30–50) containing a glucosyl moiety on the side-chains of Asn, Ser or Hyp at position 31 were synthesised. Antibody titres to hMOG(30–50) and to its glucoderivatives were measured by ELISA in sera of patients affected by different neurological diseases. Anti-hMOG(30–50) antibodies were detected only using the glycopeptide [Asn31(N-Glc)]hMOG(30–50). The glycopeptide [Asn31(N-Glc)]hMOG(30–50) is the first specific antigen able to identify anti-hMOG(30–50) antibodies [hMOG(30–50), human myelin oligodendrocyte glycoprotein 30–50] in sera of patients affected by different neurological diseases. On the contrary, [Ser31(O-Glc)]hMOG(30–50) and [Hyp31(O-Glc)]hMOG(30–50) did not allow the antibody recognition.

A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases / MAZZUCCO S; MAT S; VERGELLI M; FIORESI R; NARDI E; MAZZANTI B; CHELLI M; LOLLI F; GINANNESCHI M; PINTO F; L. MASSACESI; PAPINI A.M. - In: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - ISSN 0960-894X. - STAMPA. - 9:(1999), pp. 167-172. [10.1016/S0960-894X(98)00698-2]

A synthetic glycopeptide of human myelin oligodendrocyte glycoprotein to detect antibody responses in multiple sclerosis and other neurological diseases.

LOLLI, FRANCESCO;GINANNESCHI M;MASSACESI, LUCA;
1999

Abstract

Glycopeptides of hMOG(30–50) containing a glucosyl moiety on the side-chains of Asn, Ser or Hyp at position 31 were synthesised. Antibody titres to hMOG(30–50) and to its glucoderivatives were measured by ELISA in sera of patients affected by different neurological diseases. Anti-hMOG(30–50) antibodies were detected only using the glycopeptide [Asn31(N-Glc)]hMOG(30–50). The glycopeptide [Asn31(N-Glc)]hMOG(30–50) is the first specific antigen able to identify anti-hMOG(30–50) antibodies [hMOG(30–50), human myelin oligodendrocyte glycoprotein 30–50] in sera of patients affected by different neurological diseases. On the contrary, [Ser31(O-Glc)]hMOG(30–50) and [Hyp31(O-Glc)]hMOG(30–50) did not allow the antibody recognition.
1999
9
167
172
MAZZUCCO S; MAT S; VERGELLI M; FIORESI R; NARDI E; MAZZANTI B; CHELLI M; LOLLI F; GINANNESCHI M; PINTO F; L. MASSACESI; PAPINI A.M
File in questo prodotto:
File Dimensione Formato  
Mazzucco et al., 1999.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 373.25 kB
Formato Adobe PDF
373.25 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/254575
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 38
social impact